Ventas Valuation
Is VTR * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of VTR * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: VTR * (MX$980.33) is trading above our estimate of fair value (MX$740.45)
Significantly Below Fair Value: VTR * is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for VTR *?
Other financial metrics that can be useful for relative valuation.
What is VTR *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$19.31b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 7.7x |
Enterprise Value/EBITDA | 19.7x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does VTR *'s PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 12.5x | ||
FUNO 11 Fibra UNO | 3.8x | 5.4% | Mex$100.4b |
FSITES 20 Fideicomiso Opsimex | 13.5x | n/a | Mex$88.1b |
FIBRAPL 14 FIBRA Prologis | 16.7x | 10.1% | Mex$92.0b |
EDUCA 18 Fideicomiso Irrevocable No. F/3277 en Banco Invex S. A. Institución de Banca Múltiple INVEX Grupo | 16.2x | 3.5% | Mex$66.3b |
VTR * Ventas | 4.6x | 4.9% | Mex$19.3b |
Price-To-Sales vs Peers: VTR * is good value based on its Price-To-Sales Ratio (4.6x) compared to the peer average (9.9x).
Price to Earnings Ratio vs Industry
How does VTR *'s PE Ratio compare vs other companies in the Global Health Care REITs Industry?
Price-To-Sales vs Industry: VTR * is good value based on its Price-To-Sales Ratio (4.6x) compared to the Global Health Care REITs industry average (7x).
Price to Sales Ratio vs Fair Ratio
What is VTR *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 4.6x |
Fair PS Ratio | 5x |
Price-To-Sales vs Fair Ratio: VTR * is good value based on its Price-To-Sales Ratio (4.6x) compared to the estimated Fair Price-To-Sales Ratio (5x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.